security agreementSecurity Agreement • September 1st, 2023 • Chromocell Therapeutics Corp • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledSeptember 1st, 2023 Company Industry JurisdictionThis Security Agreement (this “Agreement”), dated as of September 1, 2023, is entered into by Chromocell Therapeutics Corporation, a Delaware corporation (the “Company” or the “Grantor”) in favor of Balmoral Financial Group LLC, a Delaware limited liability company, for itself and as collateral agent (in such capacity and together with any successor and any replacement named in accordance with the Purchase Agreement, the “Collateral Agent”) for the holders (the “Holders” or the “Purchasers”).
security agreementSecurity Agreement • July 20th, 2023 • Chromocell Therapeutics Corp • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJuly 20th, 2023 Company Industry JurisdictionThis Security Agreement (this “Agreement”), dated as of April 17, 2023, is entered into by Chromocell Therapeutics Corporation, a Delaware corporation (the “Company” or the “Grantor”) in favor of Balmoral Financial Group LLC, a Delaware limited liability company, for itself and as collateral agent (in such capacity and together with any successor and any replacement named in accordance with the Purchase Agreement, the “Collateral Agent”) for the holders (the “Holders” or the “Purchasers”).